Danimer Scientific, Inc.

NYSE:DNMR

0.3847 (USD) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q1
Revenue 7.62810.22410.94510.94812.86511.92615.32410.44812.70314.74317.72813.36914.47113.18112.02712.83511.87310.5988.7298.5977.5097.509
Cost of Revenue 16.86418.91919.53718.68519.43318.20918.02614.50314.93416.06520.0813.60112.4611.72510.8189.1888.4417.4295.715.5064.8324.832
Gross Profit -9.236-8.695-8.592-7.737-6.568-6.283-2.702-4.055-2.231-1.322-2.352-0.2322.0111.4561.2093.6473.4323.1693.0193.0912.6782.678
Gross Profit Ratio -1.211-0.85-0.785-0.707-0.511-0.527-0.176-0.388-0.176-0.09-0.133-0.0170.1390.110.1010.2840.2890.2990.3460.360.3570.357
Reseach & Development Expenses 3.1363.3115.6766.8837.7097.0757.477.9478.9137.1318.6665.013.9752.6192.2862.192.1281.2471.9711.0421.2351.235
General & Administrative Expenses 0000000000000000.1980.11200000
Selling & Marketing Expenses 0000000000000003.1722.71600000
SG&A 6.3926.51616.56416.55516.84418.69919.54719.41320.97522.23624.21226.59219.07910.1210.1653.372.8282.984.4222.7484.8294.829
Other Expenses 0.56500.20.06400.170.3990.240.0750.009-0.0620.090.030.05-0.0660.1080.0990.090000
Operating Expenses 9.5289.82722.2423.50224.55325.77427.01727.3629.88829.36732.87831.60223.05412.73912.4515.564.9564.2276.2671.8539.6739.673
Operating Income -18.764-18.522-30.832-31.239-31.121-32.227-29.71935.067-32.12-30.689-35.279-31.834-21.076-11.283-11.242-1.913-1.515-1.058-3.264-0.588-3.275-3.275
Operating Income Ratio -2.46-1.812-2.817-2.853-2.419-2.702-1.9393.356-2.529-2.082-1.99-2.381-1.456-0.856-0.935-0.149-0.128-0.1-0.374-0.068-0.436-0.436
Total Other Income Expenses Net -3.895-8.739-8.6-8.4520.981-4.5021.625-130.1791.4354.01221.22128.48260.513-83.2515.20.1080.1080.09-0.5514.959-4.718-4.718
Income Before Tax -22.659-27.261-39.432-39.691-39.302-36.729-28.094-95.112-30.685-26.677-14.256-3.59839.248-94.734-6.953-2.139-1.8-1.681-3.8154.371-7.993-7.993
Income Before Tax Ratio -2.971-2.666-3.603-3.625-3.055-3.08-1.833-9.103-2.416-1.809-0.804-0.2692.712-7.187-0.578-0.167-0.152-0.159-0.4370.508-1.064-1.064
Income Tax Expense 0.0020.0020.0020.468-0.061-0.09-0.043-0.236-0.24-0.291-1.81-11.423-60.48383.301-5.2661.32-0.0090.7130.05202.0682.068
Net Income -22.661-27.263-39.434-40.159-39.241-36.639-28.051-94.876-30.445-26.386-12.4467.82539.248-94.734-6.953-2.139-1.8-1.681-3.7634.371-10.061-10.061
Net Income Ratio -2.971-2.667-3.603-3.668-3.05-3.072-1.831-9.081-2.397-1.79-0.7020.5852.712-7.187-0.578-0.167-0.152-0.159-0.4310.508-1.34-1.34
EPS -0.19-0.26-0.39-0.39-0.38-0.36-0.28-0.94-0.3-0.26-0.120.080.44-1.12-0.26-0.025-0.021-0.02-0.0411.57-3.64-3.65
EPS Diluted -0.19-0.26-0.39-0.39-0.38-0.36-0.28-0.94-0.3-0.26-0.120.080.39-1.12-0.26-0.025-0.021-0.02-0.041.57-3.64-3.64
EBITDA -11.326-10.991-23.46-31.239-24.97-23.388-30.47131.969-29.897-31.502-35.292-31.744-18.843-9.092-11.223-1.805-0.6140.03-2.3870.309-2.409-2.409
EBITDA Ratio -1.485-1.075-2.143-2.853-1.941-1.961-1.9883.06-2.354-2.137-1.991-2.374-1.302-0.69-0.933-0.141-0.0520.003-0.2730.036-0.321-0.321